RARRES1

gene product
LXNL, TIG1
This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
251 antibodies from 23 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
OriGene
93 antibodies
Novus Biologicals
8 antibodies
LifeSpan BioSciences, Inc.
34 antibodies
Invitrogen Antibodies
6 antibodies
antibodies-online
51 antibodies
R&D Systems
2 antibodies
Abnova Corporation
5 antibodies
Aviva Systems Biology
2 antibodies
Abgent
2 antibodies
GeneTex
1 antibody
Biorbyt
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Atlas Antibodies
1 antibody
ProSci
1 antibody
MyBioSource
3 antibodies
Boster Biological Technology
1 antibody
United States Biological
16 antibodies
Creative Diagnostics
4 antibodies
Creative Biolabs
1 antibody
Sigma-Aldrich
1 antibody
St John's Laboratory
1 antibody
Acris Antibodies GmbH
2 antibodies